Federico Hawkins

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Ronald Emkey, Thomas J. Schnitzer et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

Jonathan D. Adachi, Kenneth G. Saag, P. D. Delmas et al. · Arthritis & Rheumatism · 2001 · 550 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Mutations in pregnancy‐associated plasma protein A2 cause short stature due to low IGF‐I availability

Andrew Dauber, M.T. Muñoz-Calvo, Vicente Barrios et al. · EMBO Molecular Medicine · 2016 · 212 citations · Full text

Medicine, Genetics, Molecular Biology +17

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

Matthew Austin, Yuching Yang, Eric Vittinghoff et al. · Journal of Bone and Mineral Research · 2011 · 179 citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe et al. · Journal of Bone and Mineral Research · 2013 · 173 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17